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Background: Cataract and glaucoma are both common comorbidities among older patients. Combining glaucoma
surgery with minimal invasive phacoemulsification (phaco) is a considerable option to treat both conditions at the
same time, although the combination with filtration surgery can produce a strong inflammatory response.
Combined non-penetrating procedures like canaloplasty have shown to reduce intraocular pressure (IOP)
comparable to trabeculectomy without the risk of serious bleb-related complications. The purpose of this
retrospective study was to compare the outcomes of phacotrabeculectomy and phacocanaloplasty.
Methods: Thirty-nine eyes with concomitant cataract and glaucoma who underwent phacotrabeculectomy (n = 20;
51.3%) or phacocanaloplasty (n = 19; 48.7%) were included into this trial on reduction of IOP, use of medication,
success rate, incidence of complications and postsurgical interventions. Complete success was defined as IOP
reduction by 30% or more and to 21 mmHg or less (definition 1a) or IOP to less than 18 mmHg (definition 2a)
without glaucoma medication.
Results: Over a 12-month follow-up, baseline IOP significantly decreased from 30.0 ± 5.3 mmHg with a mean of
2.5 ± 1.2 glaucoma medications to 11.7 ± 3.5 mmHg with a mean of 0.2 ± 0.4 medications in eyes with
phacotrabeculectomy (P < .0001). Eyes with phacocanaloplasty had a preoperative IOP of 28.3 ± 4.1 mmHg and
were on 2.8 ± 1.1 IOP-lowering drugs. At 12 months, IOP significantly decreased to 12.6 ± 2.1 mmHg and less
glaucoma medications were necessary (mean 1.0 ± 1.5 topical medications; P < .05). 15 patients (78.9%) with
phacotrabeculectomy and 9 patients (60.0%) in the phacocanaloplasty group showed complete success according
to definition 1 and 2 after 1 year (P = .276). Postsurgical complications were seen in 7 patients (36.8%) of the
phacocanaloplasty group which included intraoperative macroperforation of the trabeculo-Descemet membrane
(5.3%), hyphema (21.1%) and bleb formation (10.5%). Although more complications were observed in the
phacotrabeculectomy group, no statistically significant difference was found.
Conclusions: Phacocanaloplasty offers a new alternative to phacotrabeculectomy for treatment of concomitant
glaucoma and cataract, although phacotrabeculectomy yielded in better results in terms of IOP maintained
without glaucoma medications.
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There has been a widespread shift towards the perform-
ance of combined surgeries to treat both glaucoma and
cataract in one surgical setting [1-3]. In fact, incisional
glaucoma surgery in patients with medically uncontrolled
glaucoma may induce an earlier cataract development [4,5]
while performing the cataract surgery alone may not ap-
propriately lower intraocular pressure (IOP) in glaucoma
patients [6,7]. Simultaneous filtration surgery and clear
corneal phacoemulsification in elderly patients with both
cataract and glaucoma aims at reducing surgical trauma
resulting from two separate surgeries [1]. Unfortunately,
a combined procedure may induce an inflammatory re-
sponse resulting in scarring of the filtering bleb with unsat-
isfactory IOP reduction. Since filtering glaucoma surgery
requires a more intensive postoperative care than non-
penetrating glaucoma methods [8-10] some patients may
benefit from a less invasive glaucoma procedure. Several
non-filtering alternatives such as deep sclerectomy [11,12]
and viscocanalostomy [13,14] combined with cataract sur-
gery have been proposed for the management of concomi-
tant cataract and glaucoma. Although these methods may
not achieve similar low intraocular pressures as trabecu-
lectomy, their advantage could be the reduction of poten-
tial complications associated with filtering blebs.
Canaloplasty is a new non-penetrating glaucoma method
using a 360° microcatheter dilation of Schlemm canal and
a tension suture to restore the normal aqueous outflow
pathway through Schlemm canal and the collector chan-
nels. It has a lower complication rate than combined pro-
cedures using a filtering bleb and provides a better IOP
reduction when performed in combination with cataract
surgery [15-17].
In this retrospective comparative study, the safety and
efficacy profile of cataract surgery combined with trabe-
culectomy as compared to canaloplasty was investigated
in adult patients with glaucoma and cataract. To date, a
comparative analysis of phacotrabeculectomy and pha-
cocanaloplasty has not yet been reported.
Methods
Patient selection
The study protocol was approved by the ethics commit-
tee of the University of Wuerzburg, Germany. Clinical
records of consecutive patients who underwent phacoca-
naloplasty at the University Eye Hospital Wuerzburg,
Germany between June 2008 and December 2010 were
retrospectively analyzed. Data of consecutive patients who
were treated with phacotrabeculectomy and mitomycin C
(MMC) between May 2006 and December 2010 were
reviewed over an extended period of time to have a com-
parable sample size. Phacotrabeculectomy or phacocanalo-
plasty was performed in patients with visually significant
cataract and medically uncontrolled primary or secondary(pseudoexfoliative) open-angle glaucoma. Since cataract
extraction will open up the angle, three patients with
open-angle glaucoma but slightly narrow angles were also
included. In these cases, no goniosynechiae were seen on
gonioscopy prior to glaucoma surgery. Patients with ju-
venile, traumatic, neovascular or uveitic glaucoma were
excluded from the study. A total of 24 phacocanaloplasty
surgeries in 22 patients and 28 phacotrabeculectomy pro-
cedures in 28 patients were performed during the above
mentioned time periods. Nineteen eyes (48.7%) of 19
patients undergoing phacocanaloplasty and 20 eyes (51.3%)
of 20 patients undergoing phacotrabeculectomy were
included according to the above mentioned inclusion
and exclusion criteria. All phacocanaloplasty surgeries
were performed by one single surgeon. Phacotrabeculect-
omy was performed by 3 experienced glaucoma surgeons
of whom one also did all phacocanaloplasty surgeries.Evaluation of outcomes
General baseline information for each patient included
age, gender, localisation of eye undergoing surgery, type of
glaucoma, and ocular medication. Preoperatively, all
patients received a standard ophthalmic examination in-
cluding best corrected visual acuity (BCVA) measurement
converted to the logarithm of the minimum angle of
resolution (logMAR), IOP measurement using Goldmann
applanation tonometry, angle grading by gonioscopy, slit
lamp biomicroscopy of the anterior segment, and indirect
ophthalmoscopy of the optic nerve head with documenta-
tion of size of optic disc, disc cupping, presence of an
optic disc notch or splinter hemorrhage, and peripapillary
atrophy.Surgical technique
Phacotrabeculectomy
A 6 o´clock corneal traction suture was placed and a
fornix-based conjunctival flap was created. Different con-
centrations of MMC (0.2 to 0.5 mg/ml) were used accord-
ing to the estimated individual risk for future bleb scarring.
4 sponge pieces (2 x 8 mm) soaked in MMC were placed
under the conjunctival flap for 3 minutes followed by irri-
gation of the site with 30 ml balanced salt solution (BSS).
MMC 0.2 mg/ml was used in the majority of patients
(n = 14, 70.0%). In 6 eyes (30.0%) MMC 0.5 mg/ml was
applied. Thereafter, a rectangular scleral flap measuring
4 × 3 mm was dissected. Before continuing filtration
surgery, a standard phacoemulsification (phaco) technique
with a temporal clear corneal incision and posterior cham-
ber intraocular lens implantation was performed (two-site
phacotrabeculectomy). Afterwards, a trabeculectomy of
0.8 × 2 mm was performed followed by an iridectomy.
The scleral flap was secured with single sutures placed at
both corners of the scleral flap and two additional sutures
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was used to close the conjunctiva.
Phacocanaloplasty
After conjunctival incision at the 12 o´clock position, a
superficial parabolic scleral flap measuring 5 × 5 mm
was dissected and a smaller deep flap was created to
allow access to Schlemm canal. Then, phacoemulsifica-
tion and lens implantation was performed as described
above. Afterwards, the dissection of the deep flap was
continued into the clear cornea creating a trabeculo-
Descemet window. The deep scleral flap was then removed.
A laser-illuminating microcatheter (iTrack™ 250A, iScience
Interventional Corporation, Menlo Park, CA, USA) was
circumferentially inserted into Schlemm canal. After 360°
catheterization, a 10.0 prolene suture was tied to the tip of
the microcatheter and pulled back while viscoelastic
(Healon GV, Advanced Medical Optics, Inc., Santa Ana,
CA) was injected for circumferential dilation of Schlemm
canal. The suture was then tightened to permanently
stretch the trabecular meshwork. The superficial flap was
secured watertight with 10.0 vicryl suture to prevent bleb
formation followed by closure of the conjunctiva.
Postoperative management
Phacotrabeculectomy
All patients in the phacotrabeculectomy group received
prednisolone acetate eye drops every 2 hours or every
hour for one week tapering over 6 to 8 weeks, antibiotic
eye drops (gentamycin tid) for one week or as needed,
and cycloplegic eye drops (atropine bid) to prevent ma-
lignant glaucoma and reduce posterior synechiae in case
of increased anterior chamber inflammation for 1 to
2 weeks. In addition to the detailed ophthalmic examin-
ation mentioned above, IOP-lowering medication, compli-
cations, and postoperative interventions were recorded at
each visit. Laser suture lysis was used to control IOP in
the early postoperative period when IOP was elevated des-
pite successful outflow after bleb massage. Additionally,
intensive postoperative care to control wound healing
included increased topical steroid application, early sub-
conjunctival 5-fluorouracil (5-FU) or anti-VEGF injec-
tions when bleb scarring was impending, and needling
for encapsulated blebs as proposed by Marquardt and
coworkers in 2004 [18].
Phacocanaloplasty
In contrast to phacotrabeculectomy, the postsurgical re-
gime of patients in the phacocanaloplasty group consisted
of prednisolone acetate eye drops every 2 hours, non-
steroidal antiinflammatory eye drops tid, and antibiotic
eye drops (gentamycin tid) for one week or as needed. No
cycloplegic agents were given because pupil dilation may
produce an anterior synechiae of the iris to the Descemetwindow. Neither laser suture lysis was performed nor sub-
conjunctival injections of 5-FU were applied.
The postoperative treatment regime for both groups
did not differ between the 3 surgeons. Postoperative
visits were scheduled at day 1, 7, week 4, month 3, 6
and 12 or whenever they seemed clinically necessary. All
patients had at least a 12-month follow-up, which was
considered to be the final outcome. The primary endpoint
was the postoperative IOP. Secondary endpoints were vis-
ual acuity, frequency and type of complications, need for
further surgical interventions, number of topical glaucoma
medications, and the success rate based on the following
criteria: The surgery was considered complete success if
the IOP was 21 mmHg or less and the IOP was reduced
by 30% or more to baseline measures (definition 1a) or if
the IOP was less than 18 mmHg (definition 2a) without
IOP-lowering medication. Qualified success was defined
as an IOP of 21 mmHg or less and IOP reduction of more
30% compared to baseline (definition 1b) or an IOP of less
than 18 mmHg (definition 2b) with or without medical
treatment.
Anti-glaucomatous medications to control IOP were
added when laser suture lysis, subconjunctival injections
of 5-FU, bleb needling in the phacotrabeculectomy group
or Nd:YAG (Neodynium: yttrium aluminium garnet) laser
goniopuncture of the Descemet window in patients with
phacocanaloplasty failed.
Statistics
SPSS© version 19.0 for Windows (SPSS Inc., Chicago,
IL, USA) was used for statistical analyses and to create
figures. The Shapiro-Wilk test was used to assess nor-
mality of distributions. Student´s t-test was used for
continuous variables with normal distribution. One-way
analyses of variance for repeated measurements (ANOVA)
were used to examine IOP during follow-up. Differences
between groups in single discrete variables without normal
distribution were tested for significance using the Mann–
Whitney U-test. Dependent data without normal distribu-
tion was tested with the Wilcoxon signed-rank test. Cat-
egorical variables were evaluated with χ2 test (Fisher´s
exact test). Success was evaluated on the basis of Kaplan-
Meier cumulative probability (log-rank test). A maximum
two-tailed p value of <.05 indicated statistical significance.
Results
Baseline data
Thirty-nine eyes of 39 patients were included into the
study. Of these, 20 eyes of 20 patients (51.3%) had pha-
cotrabeculectomy and in 19 eyes of 19 patients (48.7%)
phacocanaloplasty was performed.
Patients´ characteristics at baseline are summarized
in Table 1. No significant difference between the two
groups was found for preoperative IOP, age, gender,
Table 1 Patients´ characteristics at baseline
Phaco trabeculectomy Phaco canaloplasty P value
n of eyes (%) 20 (51.3) 19 (48.7)
Eye (%)
Right 9 (45.0) 9 (47.4) 1.000 a
Left 11 (55.0) 10 (52.6)
Age (years)
Mean ± SD 73.6 ± 7.5 72.9 ± 5.7 .743 b
Range 59–89 64–81
Gender (%)
Male 6 (30.0) 9 (47.4) .333 a
Female 14 (70.0) 10 (52.6)
BCVA (logMAR)
Mean ± SD 0.71 ± 0.87 0.48 ± 0.39 .835 c
Range 0.00–3.00 0.10–1.70
IOP (mmHg)
Mean ± SD 30.0 ± 5.3 28.3 ± 4.1 .272 b
Range 22–39 23–37
n (%) of patients with topical medications 16 (80.0) 17 (89.5)
n (%) of patients with systemic medications 4 (20.0) 2 (10.5)
n of topical anti-glaucomatous medications
Mean ± SD 2.5 ± 1.2 2.8 ± 1.1 .309 c
Range 0–4 0–4
Type of glaucoma (%)
Primary open-angle 10 (50.0) 9 (47.4) 1.000 a
Narrow angles 2 (20.0) 1 (11.1)
Pseudoexfoliative 10 (50.0) 10 (52.6)
Previous ocular surgery (%)
None 10 (50.0) 8 (42.1) -
Laser trabeculoplasty 6 (30.0) 6 (31.6)
Cyclodestructive 2 (10.0) 4 (21.1)
Laser peripheral iridotomy* 2 (10.0) 1 (5.3)
Absolute values (percentage), unless stated otherwise. SD standard deviation.
IOP intraocular pressure, BCVA best-corrected visual acuity, logMAR log of the minimum angle of resolution, n sample size.
a χ2-test (Fisher´s exact test).
b Student´s t-test for independent samples with normal distribution (Shapiro-Wilk test was used to assess normality of distributions).
c Mann–Whitney U-test without normal distribution.
* Laser peripheral iridotomy was performed in eyes with slightly narrow angles.
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glaucoma and number of preoperative hypotensive medi-
cations. All patients completed the 1-day, 7-day, 4-week,
3-month, 6-month and 12-month follow-up.
Intraocular pressure results
At baseline, the mean IOP was 30.0 ± 5.3 mmHg (range
22–39 mmHg) in the phacotrabeculectomy group and
28.3 ± 4.1 mmHg (range 23–37 mmHg) in the phacocana-
loplasty group (P = .272). One-way ANOVA for repeatedmeasurements confirmed a highly significant difference
between baseline and follow-up within both treatment
groups (P < .0001). Mean postoperative IOP was 12.5 ±
6.1 mmHg at 1 month, 13.9 ± 6.4 mmHg at 3 months,
11.9 ± 3.9 mmHg at 6 months and 11.7 ± 3.5 mmHg at
12 months in the phacotrabeculectomy group. Patients in
the phacocanaloplasty group had a mean IOP of 14.3 ±
4.2 mmHg at 1 month, 13.5 ± 3.9 mmHg at 3 months,
14.2 ± 4.6 mmHg at 6 months and 12.6 ± 2.1 mmHg at
12 months. Although the extent of IOP reduction was
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ing follow-up, this difference was not statistically significant
(Table 2). IOP results of both groups during follow-up are
presented in Figure 1. Figure 2 shows the IOP results at
12 month compared to baseline for each patient.
Visual acuity results
BCVA was converted to the logarithm of the minimum
angle of resolution (logMAR) for statistical analyses. Mean
baseline visual acuity was 0.71 ± 0.87 logMAR in the pha-
cotrabeculectomy group and 0.48 ± 0.39 logMAR in the
phacocanaloplasty group (P = .835). BCVA was not signifi-
cantly different between both groups during follow-up.
Overall, a mean improvement in visual acuity of 0.19
logMAR in the phacocanaloplasty group and 0.28 logMAR
in the phacotrabeculectomy group was seen after 12 months
compared to baseline values (Table 3).
Change in glaucoma medication
Mean number of topical glaucoma medication at the pre-
operative visit was 2.5 ± 1.2 (range 0 to 4) and 2.8 ± 1.1
(range 0 to 4) in the phacotrabeculectomy and phacocana-
loplasty group, respectively. One patient in both groups
received only systemic medication at baseline. Preopera-
tively, 3 patients in the phacotrabeculectomy group and 1
patient in the phacocanaloplasty group needed both sys-
temic and topical IOP-lowering drugs. In the phacocanalo-
plasty group, the mean number of glaucoma medications
was 0.9 ± 1.3 at 6 months and 1.0 ± 1.5 at 12 months.
Overall, 7 and 6 patients needed anti-glaucomatous drugs
at 6 and 12 months, respectively. In contrast, three patients
of the phacotrabeculectomy group were on 1 topical glau-
coma drug at 6 months and 4 patients on 1 medication atTable 2 Intraocular pressure results
Phacotrabeculectomy
n IOP (mmHg) P value†
Baseline 20 30.0 ± 5.3 <.0001 b (n = 19)
Postoperative
1 day 20 17.7 ± 7.3
7 days 20 13.6 ± 4.8
4 weeks 20 12.5 ± 6.1
3 months 20 13.9 ± 6.4
6 months 20 11.9 ± 3.9
12 months 19~ 11.7 ± 3.5
Values are means ± SD (standard deviation).
n sample size, IOP intraocular pressure.
† during follow-up; ‡ phacotrabeculectomy versus phacocanaloplasty.
* Two patients developed filtering blebs after canaloplasty and were therefore excl
+ Two patients needed cyclodestruction to reach target IOP and were therefore exc
~ One patient underwent cyclophotocoagulation to lower IOP and was therefore ex
a Student´s t-test for independent samples with normal distribution.
b one-way repeated measures ANOVA.12 months. In both treatment groups, the mean number of
medications was significantly lower at month 6 and 12
compared to baseline. Mean number of required medica-
tion was lower in the phacotrabeculectomy group (Table 4).Success rate
In the phacotrabeculectomy group, success rates were
85.0% (17 patients) based on definition 1a (IOP of ≤21
mmHg and at least 30% reduction of IOP) and definition
2a (IOP of less than 18 mmHg) without IOP-lowering
drugs (complete success) at 6 months. At 12 months,
success rates were 78.9% (15 patients) for both criteria.
10 eyes (58.8%) and 9 eyes (60.0%) of the phacocanalo-
plasty group achieved complete success for both criteria
after 6 and 12 months, respectively. Although the suc-
cess rate was lower for patients in the phacocanalop-
lasty group, statistical analyses did not reveal significant
differences of complete success at 6 and 12 months
(P > .05; Table 5).
Qualified success was achieved by all 19 patients (100%)
of the phacotrabeculectomy group and all 15 patients
(100%) of the phacocanaloplasty group having an IOP of
less than 18 mmHg, or ≤21 mmHg and at least a 30% re-
duction of IOP after 12 months (P =1.000). There was no
statistically significant difference in qualified success found
between both groups (Table 5). Kaplan-Meier survival
plots for cumulative probability rates of success defined as
an IOP of less than 18 mmHg are shown in Figure 3.Incidence of postsurgical complications
The incidence of complications following phacotrabecu-
lectomy and phacocanaloplasty are shown in Table 6.Phacocanaloplasty P value‡
n IOP (mmHg) P value†
19 28.3 ± 4.1 <.0001 b (n = 15) .272 a
17* 12.8 ± 5.3 .029 a
17* 14.5 ± 3.9 .525 a
17* 14.3 ± 4.2 .301 a
17* 13.5 ± 3.9 .832 a
17* 14.2 ± 4.6 .111 a
15+ 12.6 ± 2.1 .357 a
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Figure 1 Intraocular pressure (IOP) outcomes of phacotrabeculectomy and phacocanaloplasty during follow-up. A highly significant
reduction of IOP was found for both groups during follow-up (P < .0001). Except for the first postoperative day, statistical analyses revealed no
significant difference for postoperative IOP results between both groups. Box plots illustrate the median (50th percentile) as a black center line
and the 25th and 75th percentile as the lower and upper hinges of the box. Circles represent minor outliers and stars major outliers.
Matlach et al. BMC Ophthalmology 2013, 13:1 Page 6 of 12
http://www.biomedcentral.com/1471-2415/13/1In the phacocanaloplasty group, one patient (5.3%) had
an intraoperative perforation of the trabeculo-Descemet
membrane. 360° dilation and insertion of a suture into
Schlemm canal was successful in all patients with phacoca-
naloplasty. In one case of the phacotrabeculectomy group,
anterior vitrectomy had to be performed and an iris claw
lens was placed (5.0%). During the early postoperative
period (≤ 90 days), there was less hypotony, defined as
IOP of <5 mmHg, in the phacocanaloplasty group than in
the phacotrabeculectomy group. Transient hypotony was
seen in 3 patients (15.0%) in the phacotrabeculectomy
group and in none of the eyes in the phacocanaloplasty
group (P = .231). Choroidal detachment occurred in 2
patients (10.0%) with phacotrabeculectomy and in none of
the phacocanaloplasty group (P = .487). Hyphema was
observed in 4 patients (21.1%) of the phacocanaloplasty
group and in 1 patients (5.0%) of the phacotrabecu-
lectomy group (P = .182). During the late postoperative
period (> 90 days), 1 patient (5.0%) of the phacotrabecu-
lectomy group had an IOP of less than 5 mmHg and chor-
oidal detachment due to a conjunctival leakage. Two
patients (10.5%) with phacocanaloplasty were reported to
have a filtering bleb. Postsurgical complications were not
found to be significantly different between both groups.Bleb management and postsurgical interventions
Table 7 summarizes the postoperative interventions for
both treatment groups, bleb management following phaco-
trabeculectomy and required procedures at the trabeculo-
Descemet window in the phacocanaloplasty group.
In the phacotrabeculectomy group, laser suture lysis was
performed in 10 eyes (50.0%) for patients with increased
IOP and flat filtering blebs, which inflated after ocular
massage. Subconjunctival injections of 5-FU were re-
peatedly given in 16 patients of the phacotrabeculect-
omy group (80.0%; 6.2 ± 3.7 injections of 5-FU, Range
0–10). We additionally applied subconjunctival injections
of anti-VEGF in the early postoperative period. In 3 cases
(15.0%) of expected increased and rapid bleb scarring,
anti-VEGF was given once before starting 5-FU. Bleb
needling became necessary in 3 patients (15.0%) of the
phacotrabeculectomy group. Nd:YAG goniopuncture of
the Descemet window was performed in 2 patients (10.5%)
of the phacocanaloplasty group. Further IOP-lowering
procedures included cyclodestructive surgeries in 1 patient
(5.0%) of the phacotrabeculectomy group and 2 patients
(10.5%) of the phacocanaloplasty group (P = .605). No
statistically significant difference in postsurgical interven-
tions was found between the two groups.
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Figure 2 Scatter plot of preoperative intraocular pressure (IOP) compared to postoperative IOP at the 12-month visit. Each circle
indicates a patient. Points below the oblique line define a lower postoperative IOP than baseline.
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Combined cataract and glaucoma surgery, both filtering
and non-penetrating, has increasingly obtained interest
due to the frequent coincidence of both conditions in
the elderly population and the frequent occurrence
of cataract progression after glaucoma surgery [1-3].Table 3 Visual acuity results
Phacotrabeculectomy
n BCVA (logMAR) P value†
Baseline 20 0.71 ± 0.87
Postoperative
1 day 20 1.32 ± 0.95 <.0001 b
7 days 20 1.14 ± 1.00 <.0001 b
4 weeks 20 1.02 ± 0.93 <.0001 b
3 months 20 0.56 ± 0.66 <.0001 b
6 months 20 0.40 ± 0.69 <.0001 b
12 months 19~ 0.43 ± 0.69 <.0001 b
Values are means ± SD (standard deviation).
n sample size, BCVA best corrected visual acuity, logMAR log of the minimum angle
† versus baseline; ‡ phacotrabeculectomy versus phacocanaloplasty.
* Two patients developed filtering blebs after canaloplasty and were therefore excl
+ Two patients needed cyclodestruction to reach target IOP and were therefore exc
~ One patient underwent cyclophotocoagulation to lower IOP and was therefore ex
a Mann–Whitney U-test for independent samples without normal distribution.
b Wilcoxon signed-rank test for dependent samples without normal distribution.Canaloplasty is a relatively new non-penetrating surgical
procedure which aims for restoring the natural aqueous
drainage pathway by circumferentially dilating Schlemm
canal using a microcatheter to viscodilate and insert a
suture into Schlemm canal to keep it permanently open.
The major advantage of this non-penetrating surgicalPhacocanaloplasty P value‡
n BCVA (logMAR) P value†
19 0.48 ± 0.39 .835 a
17* 1.17 ± 1.00 <.0001 b .537 a
17* 0.78 ± 0.46 <.0001 b .729 a
17* 0.38 ± 0.37 <.0001 b .004 a
17* 0.28 ± 0.33 <.0001 b .104 a
17* 0.27 ± 0.39 <.0001 b .821 a
15+ 0.29 ± 0.33 .001 b .607 a
of resolution.
uded.
luded.
cluded.
Table 4 Change in glaucoma medication
Phacotrabeculectomy Phacocanaloplasty P value‡
n Mean number P value† n Mean number P value†
Baseline 20 2.5 ± 1.2 19 2.8 ± 1.1 .309 a
Postoperative
1 day 20 0.0 <.0001 b 17* 0.0 <.0001 b 1.000 a
7 days 20 0.0 <.0001 b 17* 0.3 ± 0.8 <.0001 b .557 a
4 weeks 20 0.0 <.0001 b 17* 0.5 ± 1.1 .001 b .232 a
3 months 20 0.1 ± 0.3 <.0001 b 17* 0.7 ± 1.1 .001 b .167 a
6 months 20 0.2 ± 0.4 <.0001 b 17* 0.9 ± 1.3 .002 b .117 a
12 months 19~ 0.2 ± 0.4 <.0001 b 15+ 1.0 ± 1.5 .013 b .228 a
Values are means ± SD (standard deviation).
n sample size.
† versus baseline; ‡ phacotrabeculectomy versus phacocanaloplasty.
* Two patients developed filtering blebs after canaloplasty and were therefore excluded.
+ Two patients needed cyclodestruction to reach target IOP and were therefore excluded.
~ One patient underwent cyclophotocoagulation to lower IOP and was therefore excluded.
a Mann–Whitney U-test for independent samples without normal distribution.
b Wilcoxon signed-rank test for dependent samples without normal distribution.
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serious complications associated with filtering blebs. Com-
bining canaloplasty with clear corneal phacoemulsification
seems to allow further improvement of the aqueous out-
flow and provides higher IOP reduction than performed
separately due to alterations of the architecture of the
angle resulting in a more open configuration [15-17].
This clinical trial analyzed one-year results of phacotra-
beculectomy and phacocanaloplasty. The data did notTable 5 Success results
Phacotrabeculectomy
n Success
At 6 months 20
Complete success
≤ 21 mmHg + 30% IOP ↓ 17 (85.0
< 18 mmHg 17 (85.0
Qualified success
≤ 21 mmHg + 30% IOP ↓ 20 (100.0
< 18 mmHg 19 (95.0
At 12 months 19~
Complete success
≤ 21 mmHg + 30% IOP ↓ 15 (78.9
< 18 mmHg 15 (78.9
Qualified success
≤ 21 mmHg + 30% IOP ↓ 19 (100.0
< 18 mmHg 19 (100.0
Absolute values (percentage).
n sample size.
* Two patients developed filtering blebs after canaloplasty and were therefore excl
+ Two patients needed cyclodestruction to reach target IOP and were therefore exc
~ One patient underwent cyclophotocoagulation to lower IOP and was therefore ex
a χ2-test (Fisher´s exact test).reveal statistically significant differences in IOP control
between both groups. Nevertheless, postsurgical complica-
tions were more frequent seen after phacotrabeculectomy.
It is well known that cataract surgery alone can provide
a reduction of IOP, although the effect is generally small
[6,7]. IOP reduction after clear corneal phacoemulsifica-
tion is considered to be a consequence of increased out-
flow of aqueous humor due to an increased angle width
and tensioning of the trabecular meshwork. ShingletonPhacocanaloplasty P
valuen Success
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) 10 (58.8) .136 a
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Figure 3 Kaplan-Meier survival plot for cumulative probability of complete success. Success was defined as an intraocular pressure (IOP) of
less than 18 mmHg without glaucoma medication (complete success). Censored data occurred if a patient completed the 12-month visit and
maintained an IOP of less than 18 mmHg without glaucoma medication over 12 months. In the phacocanaloplasty group, the line starts below
1.0 because 2 patients developed a filtering bleb in the early postoperative period and were countered as a failure.
Table 6 Intraoperative and postoperative complications
Phacotrabeculectomy Phacocanaloplasty P value*
n of eyes (%) 20 (51.3) 19 (48.7)
Intraoperative
Microperforation TDM - 0 (0.0) -
Macroperforation TDM - 1 (5.3) -
Early postoperative (≤ 90 days)
Hypotony (IOP <5 mmHg)
n 3 (15.0) 0 (0.0) .231
Duration (days) 1–15 -
Hypotony-related:
Choroidal detachment 2 (10.0) 0 (0.0) .487
Shallow anterior chamber 1 (5.0) 0 (0.0) 1.000
5-FU-related corneal erosion 6 (30.0) - -
Hyphema≥ 1 mm layered blood 1 (5.0) 4 (21.1) .182
Late postoperative (> 90 days)
Hypotony (IOP <5 mmHg) 1 (5.0) 0 (0.0) 1.000
Choroidal detachment 1 (5.0) 0 (0.0) 1.000
Conjunctival leakage 1 (5.0) 0 (0.0) 1.000
Bleb formation - 2 (10.5) -
Absolute values (percentage).
TDM trabeculo-Descemet membrane, n sample size, IOP intraocular pressure, 5-FU 5-fluorouracil.
*χ2-test (Fisher´s exact test).
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Table 7 Postsurgical interventions and bleb management
Phacotrabeculectomy Phacocanaloplasty P value*
n of eyes (%) 20 (51.3) 19 (48.7)
Laser suture lysis
n of patients 10 (50.0) - -
Number of sutures 0.8 ± 0.9 - -
5-fluorouracil (5-FU) bleb injections
n of patients 16 (80.0) - -
Number of 5-FU injections 6.2 ± 3.7 - -
Range 0–10
VEGF-inhibitor bleb injections
n of patients 3 (15.0) - -
Number of anti-VEGF injections 0.2 ± 0.4 - -
Range 0–1
Bleb needling 3 (15.0) - -
Conjunctival suture 1 (5.0) 0 (0.0) 1.000
Scleral flap revision 2 (10.0) - -
Nd:YAG laser goniopuncture - 2 (10.5) -
Iridoplasty - 1 (5.3) -
Additional IOP-lowering procedures
Cyclodestructive 1 (5.0) 2 (10.5) .605
Absolute values (percentage).
VEGF vascular endothelial growth factor, Nd:YAG Neodynium: neodymium yttrium aluminium garnet, IOP intraocular pressure, n sample size.
*χ2-test (Fisher´s exact test).
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tained 5 years after cataract surgery. In contrast, IOP is
often increased in the early postoperative period in glau-
comatous eyes after cataract surgery [6].
Interestingly, several comparative studies on trabe-
culectomy and phacotrabeculectomy found a higher
incidence of postoperative adverse events with the com-
bined procedure. These were mostly induced by an in-
flammatory response that would limit the efficacy on IOP
reduction [2,19,20]. Lochhead et al. [20] reported that
phacotrabeculectomy was not as effective as trabecu-
lectomy alone in reducing IOP. A possible mechanism
that leads to a smaller IOP reduction following phaco-
trabeculectomy may be the prolonged anterior cham-
ber inflammation due to an altered blood-aqueous
barrier [20].
In contrast to outcomes of combined filtering glaucoma
surgeries, studies on non-penetrating glaucoma surgery
combined with cataract surgery showed a better IOP-
lowering effect of combined techniques [12,13,16]. Bull
et al. [16] examined clinical outcomes of canaloplasty
compared to phacocanaloplasty and found better results
on IOP reduction in combined surgical cases than in cases
with canaloplasty alone. In a multicenter-study conducted
by Lewis and co-authors [17], 3-year results of canaloplasty
and phacocanaloplasty were reported. They concluded thatboth methods led to a significant and sustained IOP reduc-
tion with a low incidence of postoperative complications.
Additionally, other clinical trials found a conjunctive effect
of non-penetrating glaucoma surgery such as viscocana-
lostomy [13,14] or deep sclerectomy [11,12], when per-
formed in combination with cataract surgery.
In our study, we found a 12-month IOP of 11.7 ±
3.5 mmHg for eyes undergoing phacotrabeculectomy,
which was lower than in patients treated with phacocana-
loplasty (12.6 ± 2.1 mmHg), although this difference was
not statistically significant (P = .357). Additionally, the
phacotrabeculectomy group needed fewer glaucoma med-
ications (0.2 ± 0.4) compared to the phacocanaloplasty
group (1.0 ± 1.5) at 1 year (P = .228). These results might
be taken into the surgeon´s considerations, if a higher
IOP reduction is necessary in patients with advanced glau-
coma or if topical glaucoma drugs are not tolerated.
Recently, a study by Ayyala et al. [10], comparing surgical
outcomes of canaloplasty and trabeculectomy without sim-
ultaneous cataract surgery, also found lower IOP with a
lower percentage of patients needing postoperative anti-
glaucomatous medications for the trabeculectomy group.
In general, studies on combined glaucoma surgeries
report a postoperative IOP for phacotrabeculectomy com-
parable to our results [11,14,20]. For phacocanaloplasty,
1-year outcomes of IOP ranging from 13.7 mmHg to
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Additionally, non-penetrating surgical methods such as
deep sclerectomy [11,12] and viscocanalostomy [13,14] in
combination with cataract surgery led to similar 1-year
results of IOP reduction.
In fact, it is difficult to compare the incidence of com-
plications between a penetrating and a non-penetrating
glaucoma procedure. Nevertheless, severe hypotony-related
complications are more frequent seen after trabeculect-
omy. In our study, hypotony (15.0%), choroidal detach-
ment (10.0%) and shallow anterior chamber (5.0%) were
seen in the phacotrabeculectomy group whereas in none
of the patients in the phacocanaloplasty group. In litera-
ture, studies report an incidence of hypotony ranging
from 18.5% to 20%, choroidal detachment in the range
of 9.3% to 20% and a flattening of the anterior chamber
in 0% to 10% following phacotrabeculectomy during 1
to 3 years of follow-up [14,19].
Several studies comparing non-penetrating with trad-
itional incisional glaucoma surgery with or without cata-
ract surgery confirmed lower rates of severe postoperative
complications for non-penetrating procedures [8-11,14].
In our study, hyphema was seen in 21.1% of patients with
phacocanaloplasty and is a common event after canalo-
plasty. Hyphema seems to be a positive prognostic value
regarding IOP development, since postsurgical interven-
tions to reach target IOP became significantly fewer ne-
cessary in patients with a microhyphema [21]. Grieshaber
and co-authors concluded that a hyphema may indicate a
patent physiologic aqueous drainage system [21]. While
dilating Schlemm canal with viscoelastics, a detachment of
Descemet membrane may occur. An intracorneal hematoma
is a rare complication following Descemet detachment
and can be removed by partial-thickness paracentesis
[22]. Descemet detachment was not encountered in our
study. Overall, complication rate for phacocanaloplasty
in our study was low and is comparable to previously
published studies [10,15-17]. Bull and coauthors [16]
reported a 12.8% incidence of microhyphema, hyphema
in 5.5% and Descemet detachment in 3.7%. No hypotony
or shallow anterior chamber was seen after canaloplasty
and phacocanaloplasty during the early postoperative
period [16].
Postoperative bleb manipulation to enhance flow such as
focal massage, laser suture lysis, subconjunctival applica-
tion of antimetabolites and bleb needling is often required
after trabeculectomy. Since canaloplasty is a non-filtering,
bleb-independent surgical approach, this might be a bene-
ficial advantage compared to trabeculectomy.
Several limitations of this study have to be discussed. This
trial was a retrospective and non-randomized; comparison
of two separate series commonly having more sources of
error due to confounding and selection bias than pros-
pective studies. Additionally, phacotrabeculectomy andphacocanaloplasty were performed by more than one sur-
geon, though in the same surgical center. Despite the limi-
tation imposed by inclusion of surgical data of different
surgeons, both groups had similar preoperative demo-
graphic characteristics and the postoperative care was iden-
tical for all included patients. Individual predictive factors
influencing the long-term outcomes of both combined sur-
gical approaches are needed to decide whether a filtering or
non-filtering methods lead to better results.
Conclusions
In conclusion, phacotrabeculectomy and phacocanaloplasty
resulted in a significant reduction of IOP after 12 months.
Nevertheless, IOP was higher and more glaucoma medica-
tions were required in patients who underwent phacocana-
loplasty. Although canaloplasty may not achieve as low
pressures as trabeculectomy, combining canaloplasty with
cataract surgery may be a valuable alternative to traditional
combination of incisional glaucoma surgery and phacoe-
mulsification, since the newer techniques produce moderate
IOP reduction comparable to phacotrabeculectomy, have
lower rates of postoperative complications and do not need
an intensive postoperative care. These results on compar-
ing filtering with non-filtering glaucoma surgery need to
be confirmed in prospective randomized studies.
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